Literature DB >> 20816671

Mechanisms of metformin action on glucose transport and metabolism in human adipocytes.

Jean Grisouard1, Katharina Timper, Tanja M Radimerski, Daniel M Frey, Ralph Peterli, Blerina Kola, Márta Korbonits, Paul Herrmann, Stephan Krähenbühl, Henryk Zulewski, Ulrich Keller, Beat Müller, Mirjam Christ-Crain.   

Abstract

The mechanisms of metformin effects on glucose transport and metabolism were investigated in human adipocytes. Human preadipocytes obtained from surgical biopsies were differentiated in vitro into adipocytes and the effects of metformin on glucose uptake, glucose oxidation and the involved signaling pathways were analyzed. Metformin (1mM, 24h) increased glucose uptake 2.3±0.2-fold (p<0.001 vs. basal) in human adipocytes, without altering cell viability and oxygen consumption. Metformin did not alter GLUT-1 mRNA expression and protein content but increased GLUT-4 mRNA expression and cellular protein content, leading to increased GLUT-4 protein content in the plasma membrane. Neither basal nor insulin-induced phosphorylation of Akt at Ser-473 and AS160 (Akt substrate of 160kDa) at Thr-642 were enhanced by metformin. Suppression of metformin-induced AMP-activated protein kinase (AMPK) activity by AMPKα1 silencing, however, reduced metformin-associated GLUT-4 expression and stimulation of glucose uptake. In addition, metformin induced glucose oxidation. In conclusion, activation of AMPKα1 without impairment of cell respiration is crucial for metformin-mediated increase in GLUT-4 protein content and glucose uptake in human adipocytes.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816671     DOI: 10.1016/j.bcp.2010.08.021

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.

Authors:  Emilie Bahne; Emily W L Sun; Richard L Young; Morten Hansen; David P Sonne; Jakob S Hansen; Ulrich Rohde; Alice P Liou; Margaret L Jackson; Dayan de Fontgalland; Philippa Rabbitt; Paul Hollington; Luigi Sposato; Steven Due; David A Wattchow; Jens F Rehfeld; Jens J Holst; Damien J Keating; Tina Vilsbøll; Filip K Knop
Journal:  JCI Insight       Date:  2018-12-06

2.  Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.

Authors:  Arron Sikka; Manjinder Kaur; Chapla Agarwal; Gagan Deep; Rajesh Agarwal
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

Review 3.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

4.  Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus.

Authors:  Tamer Ahmed Ismail; Mohamed Mohamed Soliman; Mohamed Abdo Nassan
Journal:  Exp Ther Med       Date:  2015-03-13       Impact factor: 2.447

5.  Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?

Authors:  Mojca Jensterle; Nika Aleksandra Kravos; Vita Dolžan; Katja Goričar; Rok Herman; Manfredi Rizzo; Andrej Janež
Journal:  Endocrine       Date:  2021-11-10       Impact factor: 3.633

6.  The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.

Authors:  A Slominski; T-K Kim; A A Brożyna; Z Janjetovic; D L P Brooks; L P Schwab; C Skobowiat; W Jóźwicki; T N Seagroves
Journal:  Arch Biochem Biophys       Date:  2014-07-02       Impact factor: 4.013

7.  Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity.

Authors:  Antje Bruckbauer; Michael B Zemel
Journal:  Diabetes Metab Syndr Obes       Date:  2013-02-13       Impact factor: 3.168

8.  Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation.

Authors:  Jean Grisouard; Kaethi Dembinski; Doris Mayer; Ulrich Keller; Beat Müller; Mirjam Christ-Crain
Journal:  Diabetol Metab Syndr       Date:  2011-07-20       Impact factor: 3.320

9.  Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes.

Authors:  Qing He; Qing-chan Yang; Qin Zhou; Hui Zhu; Wen-yan Niu; Jing Feng; Yan Wang; Jie Cao; Bao-yuan Chen
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

Review 10.  Management of pediatric and adolescent type 2 diabetes.

Authors:  M Constantine Samaan
Journal:  Int J Pediatr       Date:  2013-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.